About Tympanogen
Tympanogen is a company based in Norfolk (United States) founded in 2014.. Tympanogen has raised $2.18 million across 7 funding rounds from investors including HHS, Virginia Catalyst and Center for Innovative Technology. Tympanogen offers products and services including Perf-Fix. Tympanogen operates in a competitive market with competitors including AventaMed, Preceptis Medical, NousQ, Doya Medical and EntraTympanic, among others.
- Headquarter Norfolk, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Tympanogen, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$2.18 M (USD)
in 7 rounds
-
Latest Funding Round
$1.16 M (USD), Seed
Feb 10, 2025
-
Investors
HHS
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Tympanogen
Tympanogen offers a comprehensive portfolio of products and services, including Perf-Fix. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Nonsurgical treatment for eardrum repair using innovative gel system.
Unlock access to complete
Unlock access to complete
Funding Insights of Tympanogen
Tympanogen has successfully raised a total of $2.18M across 7 strategic funding rounds. The most recent funding activity was a Seed round of $1.16 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Seed — $1.2M
- First Round First Round
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2025 | Amount | Seed - Tympanogen | Valuation |
investors |
|
| May, 2023 | Amount | Seed - Tympanogen | Valuation |
investors |
|
| Apr, 2022 | Amount | Seed - Tympanogen | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Tympanogen
Tympanogen has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Virginia Catalyst and Center for Innovative Technology. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage VC firm funding companies in the US
|
Founded Year | Domain | Location | |
|
Early-stage entrepreneurs are accelerated through MassChallenge's program.
|
Founded Year | Domain | Location | |
|
Virginia Catalyst is focused on life sciences funding initiatives.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Tympanogen
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Tympanogen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Tympanogen Comparisons
Competitors of Tympanogen
Tympanogen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AventaMed, Preceptis Medical, NousQ, Doya Medical and EntraTympanic, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Device for safe placement of grommets
|
|
| domain | founded_year | HQ Location |
Surgical tools for pediatric ear tube procedures are developed.
|
|
| domain | founded_year | HQ Location |
Developer of a robotic surgical applicator for ear tube surgery. This device aims to simplify the procedure, reducing the need for general anesthesia and a surgical microscope. It enables outpatient settings and potentially reduces costs. The applicator uses commercially available ear tubes and features safety and precision enhancements through robotics and sensor technology. It makes a precise incision on the eardrum, improving outcomes for patients.
|
|
| domain | founded_year | HQ Location |
Develops non-invasive stent technology for treating otitis media with effusion.
|
|
| domain | founded_year | HQ Location |
Medical device for the treatment of middle ear infections
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Tympanogen
Frequently Asked Questions about Tympanogen
When was Tympanogen founded?
Tympanogen was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Where is Tympanogen located?
Tympanogen is headquartered in Norfolk, United States. It is registered at Norfolk, Virginia, United States.
Is Tympanogen a funded company?
Tympanogen is a funded company, having raised a total of $2.18M across 7 funding rounds to date. The company's 1st funding round was a Seed of $1M, raised on May 19, 2016.
What does Tympanogen do?
Provider of gel patch for chronic tympanic membrane perforations. The company develops products for chronic tympanic membrane perforations to treat middle ear infections which may result in hearing loss, nerve, and brain damage. Unlike the invasive surgical procedures, the companys patent-pending gel patch product called Perf-Fix is used in an in-clinic procedure; It promotes tissue regrowth, prevents infections.
Who are the top competitors of Tympanogen?
Tympanogen's top competitors include Preceptis Medical, AventaMed and NousQ.
What products or services does Tympanogen offer?
Tympanogen offers Perf-Fix.
Who are Tympanogen's investors?
Tympanogen has 4 investors. Key investors include HHS, Virginia Catalyst, Center for Innovative Technology, and MassChallenge.